Seminar Series: Dr. Thomas Velenosi, “Using pharmacometabolomics to reveal metabolic biomarkers of treatment response in triple-negative breast cancer” "
Seminar Series: Dr. Thomas Velenosi, “Using pharmacometabolomics to reveal metabolic biomarkers of treatment response in triple-negative breast cancer” "
